We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

DynaCT in Preoperative Imaging Before Insertion of Stentgraft (DynaCT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01146639
First Posted: June 17, 2010
Last Update Posted: January 18, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Norwegian University of Science and Technology
  Purpose
Endovascular therapy of Aortic Aneurysms depends on good imaging facilities. A relatively new kind of x-ray equipment makes it possible to create computer tomography (CT) - like slice images in the operating room. The purpose of this study is to verify the clinical usefulness of DynaCT in a preoperative setting. To do so we compare aortic measurements in DynaCT to the same measurements in ordinary CT-images which are regarded the gold standard.

Condition Intervention
Abdominal Aortic Aneurysm Radiation: DynaCT Drug: Iodixanol

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Usefulness of DynaCT Compared to Multidetector CT as Preoperative Imaging Before Insertion of Aortic Stentgraft.

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Verify clinical usefulness of DynaCT images in preoperative imaging. [ Time Frame: One year ]

Enrollment: 20
Study Start Date: August 2008
Study Completion Date: June 2010
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: MDCT and additional DynaCT Radiation: DynaCT
One extra set of images with DynaCT including one extra injection of contrast medium.
Drug: Iodixanol
One extra set of images with DynaCT including one extra injection of 50 ml contrast medium.
Other Name: Visipaque Amersham Health 270 mg I/ml

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Not inserted stent graft before.
  • Patiens over 60 Years old.
  • Able to give informed consent.

Exclusion Criteria: Not

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01146639


Locations
Norway
St Olavs Hospital, Operating Room of the Future.
Trondheim, Norway
Sponsors and Collaborators
Norwegian University of Science and Technology
  More Information

Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT01146639     History of Changes
Other Study ID Numbers: rek 4.2008.802
First Submitted: June 16, 2010
First Posted: June 17, 2010
Last Update Posted: January 18, 2017
Last Verified: January 2017

Keywords provided by Norwegian University of Science and Technology:
EVAR DynaCT

Additional relevant MeSH terms:
Aneurysm
Aortic Aneurysm
Aortic Aneurysm, Abdominal
Vascular Diseases
Cardiovascular Diseases
Aortic Diseases